PCK1 and pancreatic neoplasm: Recent research findings have documented elevated expression levels of PCK1 (or PCK2) in various cancers, such as colon cancer, pancreatic cancer, lung cancer, melanoma, lymphoma, and metastatic breast cancer cells [18–21].